Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


District of Columbia2


Wyoming2


Alaska2


North Dakota2


Vermont2


South Dakota2


Delaware2


Montana2


Rhode Island2


Hawaii7


New Hampshire2


New Mexico7


Maine2


Idaho7


Nebraska2


West Virginia2


Nevada2


Utah7


Mississippi2


Puerto Rico2


Kansas2


Arkansas2


Oklahoma2


Iowa7


Alabama2


Oregon2


Connecticut7


Louisiana7


South Carolina2


Colorado2


Kentucky7


Maryland2


Arizona2


Tennessee2


Missouri2


Indiana2


Wisconsin2


Minnesota2


Massachusetts2


Virginia2


Washington1


Georgia7


North Carolina2


Michigan2


New Jersey7


Ohio2


Illinois7


Pennsylvania2


New York7


Texas7


Florida2


California7





Notes:
Created by statecancerprofiles.cancer.gov on 03/21/2026 9:40 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.